AbbVie Inc (ABBV)

175.58 +4.06 (+2.37%) USD  |  NYSE  |  Dec 20, 16:00
175.50 -0.08 (-0.05%) After-Hours: 20:00
More

AbbVie Debt to Equity Ratio: 11.78 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Amgen Inc 8.024
Johnson & Johnson 0.5096
Eli Lilly and Co 2.185
Merck & Co Inc 0.8568
Pfizer Inc 0.7219

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 143.42B
Total Liabilities (Quarterly) 137.35B
Shareholders Equity (Quarterly) 6.032B
Current Ratio 0.6452
Net Debt Paydown Yield -0.58%